Escherichia coli Mutators Present an Enhanced Risk for Emergence of Antibiotic Resistance during Urinary Tract Infections

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 1, 2004, Pages 23-29

  Miller, Keith ^a   O'Neill, Alexander John ^a   Chopra, Ian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; GENTAMICIN; RIBOSOME PROTEIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIUM MUTANT; CELL TYPE; CONTROLLED STUDY; DISEASE SIMULATION; ENTEROBACTER INFECTION; ESCHERICHIA COLI; EVALUATION; INFECTION RISK; MICROBIAL SENSITIVITY TEST; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RISK FACTOR; SPECIES COMPARISON; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ETHIDIUM; FLUOROMETRY; GENE FREQUENCY; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TETRAHYDROFOLATE DEHYDROGENASE; URINARY TRACT INFECTIONS;

EID: 0347362473     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.1.23-29.2004     Document Type: Article

References (38)

1. Adrian, P. V., and K. P. Klugman. 1997. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2406-2413.
2. Alekshun, M. N., and S. B. Levy. 1997. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:2067-2075.
3. Bannon, J., M. H. Hatem, and M. Noone. 1998. Anaerobic infections of the urinary tract: are they being missed? J. Clin. Pathol. 51:709-710.
4. Baquero, F. 2001. Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist. Updates 4:93-105.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Brenwald, N. P., M. J. Gill, and R. Wise. 1998. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2032-2035.
7. Buckel, P., A. Buchberger, A. Bock, and H. G. Wittmann. 1977. Alteration of ribosomal protein L6 in mutants of Escherichia coli resistant to gentamicin. Mol. Gen. Genet. 158:47-54.
8. Chai, T., and J. Foulds. 1978. Two bacteriophages which utilize a new Escherichia coli major outer membrane protein as part of their receptor. J. Bacteriol. 135:164-170.
9. Chopra, I., A. J. O'Neill, and K. Miller. 2003. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist. Updates 6:137-145.
10. Denamur, E., S. Bonacorsi, A. Giraud, P. Duriez, F. Hilali, C. Amorin, E. Bingen, A. Andremont, B. Picard, F. Taddei, and I. Matic. 2002. High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J. Bacteriol. 184:605-609.
11. Finch, R. G. 1997. Tetracyclines, p. 475-484. In F. O'Grady, H. P. Lambert, R. G. Finch, and D. Greenwood (ed.), Antibiotic and chemotherapy, 7th ed. Churchill Livingstone, New York, N.Y.
12. Frimodt-Moller, N. 2002. Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int. J. Antimicrob. Agents 19:546-553.
13. Hughes, D. T. D. 1997. Diaminopyrimidines, p. 346-356. In F. O'Grady, H. P. Lambert, R. G. Finch, and D. Greenwood (ed.), Antibiotic and chemotherapy, 7th ed. Churchill Livingstone, New York, N.Y.
14. Jaffe, A., Y. A. Chabbert, and O. Semonin. 1982. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams. Antimicrob. Agents Chemother. 22:942-948.
15. Kucers, A., and N. M. Bennet. 1989. The use of antibiotics, 4th ed. Heinemann Medical Books, Edinburgh, United Kingdom.
16. Liu, Y. C., W. K. Huang, T. S. Huang, and C. M. Kunin. 1999. Detection of antimicrobial activity in urine for epidemiologic studies of antibiotic use. J. Clin. Epidemiol. 52:539-545.
17. Martinez, J. L., and F. Baquero. 2000. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44:1771-1777.
18. Maskell, J. P., A. M. Sefton, and L. M. C. Hall. 2001. Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:1104-1108.
19. Matthews, D. A., J. T. Bolin, J. M. Burridge, D. J. Filman, K. W. Volz, B. T. Kaufman, C. R. Beddell, J. N. Champness, D. K. Stammers, and J. Kraut. 1985. Refined crystal-structures of Escherichia coli and chicken liver dihydrofolate-reductase containing bound trimethoprim. J. Biol. Chem. 260:381-391.
20. Miller, J. H. 1992. A short course in bacterial genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
21. Miller, K., A. J. O'Neill, and I. Chopra. 2002. Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J. Antimicrob. Chemother. 49:925-934.
22. Naber, K. G. 2000. Survey on antibiotic usage in the treatment of urinary tract infections. J. Antimicrob. Chemother. 46:49-52.
23. Normark, B. H., and S. Normark. 2002. Evolution and spread of antibiotic resistance. J. Intern. Med. 252:91-106.
24. Oethinger, M., W. V. Kern, A. S. Jellen-Ritter, L. M. McMurry, and S. B. Levy. 2000. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44:10-13.
25. Oethinger, M., I. Podglajen, W. V. Kern, and S. B. Levy. 1998. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 42:2089-2094.
26. Oliver, A., R. Canton, P. Campo, F. Baquero, and J. Blazquez. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1253.
27. O'Neill, A. J., J. M. Bostock, A. M. Moita, and I. Chopra. 2002. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J. Antimicrob. Chemother. 50:839-848.
28. Patel, K. B., D. P. Nicolau, C. H. Nightingale, and R. Quintiliani. 1995. Pharmacokinetics of cefotaxime in healthy-volunteers and patients. Diagn. Microbiol. Infect. Dis. 22:49-55.
29. Phillips, I., and K. P. Shannon. 1997. Aminoglycosides and aminocylitols, p. 164-201. In F. O'Grady, H. P. Lambert, R. G. Finch, and D. Greenwood (ed.), Antibiotic and chemotherapy, 7th ed. Churchill Livingstone, New York, N.Y.
30. Rahaman, S. O., J. Mukherjee, A. Chakrabarti, and S. Pal. 1998. Decreased membrane permeability in a polymyxin B-resistant Escherichia coli mutant exhibiting multiple resistance to beta-lactams as well as aminoglycosides. FEMS Microbiol. Lett. 161:249-254.
31. Reddy, J. 1981. Tetracycline antibiotics should be avoided in patients with renal-disease. N. Z. Med. J. 94:396.
32. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Segura, J. W., P. P. Kelalis, W. J. Martin, and L. H. Smith. 1972. Anaerobic bacteria in the urinary tract. Mayo Clin. Proc. 47:30-33.
34. Stamm, W. E. 1992. Approach to the patient with urinary tract infection, p. 788-798. In S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow (ed.), Infectious diseases. The W. B. Saunders Co., Philadelphia, Pa.
35. Sulavik, M. C., C. Houseweart, C. Cramer, N. Jiwani, N. Murgolo, J. Greene, B. DiDomenico, K. J. Shaw, G. H. Miller, R. Hare, and G. Shimer. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45:1126-1136.
36. Thillet, J., J. Absil, S. R. Stone, and R. Pictet. 1988. Site-directed mutagenesis of mouse dihydrofolate-reductase-mutants with increased resistance to methotrexate and trimethoprim. J. Biol. Chem. 263:12500-12508.
37. Wilson, A. P. R., and R. N. Gruneberg. 1997. Ciprofloxacin: 10 years of clinical experience, 1st ed. Maxim Medical, Oxford, United Kingdom.
38. Zhao, X. L., and K. Drlica. 2002. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window. J. Infect. Dis. 185:561-565.